National Institute of Pharmaceutical Education and Research, Raebareli has entered into a strategic collaboration with Lofty Laboratories through the signing of a Memorandum of Understanding (MoU), Confidential Disclosure Agreement (CDA), and Technology Transfer Agreement aimed at accelerating indigenous biotechnology innovation and commercialization.
The partnership reflects a growing industry-academia synergy focused on translating research-driven innovations into commercially viable healthcare solutions. Through this collaboration, both organisations aim to strengthen technology development, facilitate knowledge exchange, and promote the commercialisation of homegrown biotech technologies in India.
The agreements are expected to support collaborative research initiatives, industrial training opportunities, and faster transfer of scientific advancements from laboratory to market. The initiative also aligns with India’s broader vision of strengthening self-reliance in pharmaceuticals and biotechnology under the “Make in India” and innovation-driven healthcare ecosystem.
The collaboration marks another important step toward building a robust and innovation-oriented biotechnology sector in the country.
